Sponsor:
Centre hospitalier de l'Université de Montréal (CHUM)
Code:
NCT05806021
Conditions
Primary Gonarthrosis
Eligibility Criteria
Sex: All
Age: 50+
Healthy Volunteers: Accepted
Interventions
Triamcinolone Acetonide
Brief summary:
Conditions
Primary Gonarthrosis
Study ID
NCT05806021
Start date
Jan 15, 2024
Status verified date
Feb, 2025
Completion date
Feb, 2026
Anticipated
Primary completion date
Dec, 2025
Anticipated
Eligibility Criteria
Sex: All
Age: 50+
Healthy Volunteers: Accepted
Enrollment
327 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: Group A TA 40 mg
active comparator: Group B TA 10 mg
active comparator: Group C TA 5 mg
Interventions
Triamcinolone Acetonide
Primary outcome measure
Central contacts
Locations
Centre Hospitalier Universitaire de Montréal - Hôtel-Dieu
Recruiting
Montréal, Quebec, Canada, H2W 1T8
Contacts
Principal Investigator:
Dien Hung Luong, MD
Sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
Last update posted
Feb 5, 2025
Last verified
Feb, 2025
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Centre hospitalier de l'Université de Montréal (CHUM) on 2025-02-05.